TriSalus Life Sciences annual revenue
2022
2023
2024
2025
TriSalus Life Sciences Revenue Growth & History (TLSI)
TriSalus Life Sciences reported $45.2M in revenue for fiscal 2025, an increase of 53.41% from the previous fiscal year.
View full TriSalus Life Sciences company overviewTriSalus Life Sciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $45.2M | $15.7M | +53.41% |
| 2024 | 2024-12-31 | $29.4M | $10.9M | +58.99% |
| 2023 | 2023-12-31 | $18.5M | $6.1M | +49.31% |
| 2022 | 2022-12-31 | $12.4M | — | — |
TriSalus Life Sciences quarterly revenue
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.4M | $194,000 | +1.73% |
| Q1 2026 | 2026-03-31 | $8.9M | −$268,000 | −2.92% |
| Q4 2025 | 2025-12-31 | $13.2M | $4.9M | +59.85% |
| Q3 2025 | 2025-09-30 | $11.6M | $4.2M | +57.38% |
| Q2 2025 | 2025-06-30 | $11.2M | $3.8M | +52.27% |
| Q1 2025 | 2025-03-31 | $9.2M | $2.7M | +41.97% |
| Q4 2024 | 2024-12-31 | $8.3M | $2.5M | +44.37% |
| Q3 2024 | 2024-09-30 | $7.3M | $2.2M | +41.52% |
| Q2 2024 | 2024-06-30 | $7.4M | $2.8M | +59.67% |
| Q1 2024 | 2024-03-31 | $6.5M | $3.5M | +116.39% |
| Q4 2023 | 2023-12-31 | $5.7M | — | — |
| Q3 2023 | 2023-09-30 | $5.2M | $1.3M | +32.37% |
| Q2 2023 | 2023-06-30 | $4.6M | — | — |
| Q1 2023 | 2023-03-31 | $3.0M | — | — |
| Q3 2022 | 2022-09-30 | $3.9M | — | — |
TriSalus Life Sciences revenue growth trends
TriSalus Life Sciences's latest reported quarter, Q2 2026, generated $11.4M in revenue, an increase of 1.73% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review TriSalus Life Sciences source filings ↗